G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Manager – Regulatory Affairs CMC with Viral Vector experience

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeHoofddorp, NetherlandsNo salary listedHybrid

About the Job

Requirements

  • Relevant industry experience focused on viral vectors and/or lipid nanoparticles is required.
  • At least 8 years of Regulatory Affairs or relevant industry experience following a Bachelor’s Degree is required.
  • A sound understanding of ICH and regional regulatory requirements for assigned territories, and current global and regional trends in Regulatory Affairs CMC, is required.
  • Proven ability to drive cross-functional deliverables and influence stakeholders without direct authority, ensuring alignment, timely decisions, and high-quality execution, is required.
  • Ability to build trust and rapport quickly and establish effective working relationships across functions, sites, and geographies is required.
  • Ability to align diverse perspectives into a coherent regulatory CMC strategy that balances compliance, timelines, and operational feasibility is required.
  • Demonstrated experience reviewing, drafting, and editing regulatory, scientific, or technical documents is required.
  • Excellent written and verbal command of English, including the ability to convey complex scientific and regulatory concepts clearly and precisely, is required.
  • Strong organizational skills and attention to detail are required.
  • Self-motivation and a strong sense of ownership and accountability are required.
  • Ability to operate in a fast-paced environment with changing priorities and strict timelines is required.
  • A flexible, solution-oriented mindset and ability to adapt best practices within a growing organization are required.
  • Proficiency with industry-standard software tools is required.

Responsibilities

  • Act as the Regulatory Affairs CMC Lead for assigned clinical and commercial cell therapy programs, ensuring high-quality and timely regulatory CMC deliverables.
  • Contribute to developing and executing CMC regulatory strategies aligned with product development stage, regional requirements, and overall program objectives.
  • Author, review, and critically assess regulatory CMC documentation for accuracy, consistency, and compliance.
  • Provide regulatory CMC guidance and input to cross-functional teams supporting product development, lifecycle management, and commercialization.
  • Interpret and apply EMA, EU, Ph. Eur., and relevant rest-of-world regulatory requirements, including ATMP-specific expectations and practical implementation.
  • Support alignment of cross-functional perspectives into a consistent regulatory CMC position, balancing compliance, timelines, and operational feasibility.
  • Assess proposed CMC change controls to determine their regulatory impact across clinical and commercial programs.
  • Maintain accurate, current internal regulatory IT systems aligned with regulatory activities to enable reliable tracking of submissions, status, and commitments across programs.
  • Participate in industry trade groups and regulatory professionals associations.
  • Lead updates to the corporation on major international CMC regulatory guidance for assigned areas of interest.
  • Use the industry network to maintain awareness of CMC best practices and disseminate relevant information to the corporation.
  • Assist in drafting background packages for Health Authority meetings and, as required, develop basic strategies.
  • Form ad hoc task forces to address critical CMC issues for project and department teams.

Desired Qualifications

  • Advanced degrees, including a PhD or MS, or certificates are desired.
  • Proficiency in Dutch is a plus.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs